XBiotech (XBIT) Consolidated Net Income (2014 - 2026)

XBiotech's Consolidated Net Income history runs 12 years deep, the most recent figure standing at -$26.9 million for Q4 2025.

• In Q4 2025, Consolidated Net Income fell 155.92% year-over-year to -$26.9 million; the TTM figure through Dec 2025 stood at -$45.5 million (down 18.19% YoY), while the FY2025 annual figure was -$45.5 million, down 18.19% from the prior year.
• Consolidated Net Income for Q4 2025 stood at -$26.9 million, down from -$6.0 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$1.8 million in Q2 2025, with the low at -$26.9 million in Q4 2025.
• The 5-year median for Consolidated Net Income is -$5.7 million (2022), against an average of -$7.9 million.
• The sharpest annual moves came in 2021 and 2025: Consolidated Net Income tumbled 18242.86% in 2021, then surged 86.5% in 2025.
• XBiotech's Consolidated Net Income stood at -$5.1 million in 2021, then jumped by 36.65% to -$3.2 million in 2022, then plunged by 46.55% to -$4.7 million in 2023, then tumbled by 123.86% to -$10.5 million in 2024, then tumbled by 155.92% to -$26.9 million in 2025.
• Business Quant data shows XBIT's Consolidated Net Income at -$26.9 million in Q4 2025, -$6.0 million in Q3 2025, and -$1.8 million in Q2 2025.